menu search

MGTX / MeiraGTx shares jump as Sanofi invests in gene therapy

MeiraGTx shares jump as Sanofi invests in gene therapy
Shares of MeiraGTx Holdings PLC MGTX, -4.88% jumped 14% premarket on Monday after the gene therapy company announced that French drugmaker Sanofi SNY, -19.13% has made a $30 million investment. Read More
Posted: Oct 30 2023, 08:28
Author Name: Market Watch
Views: 091910

MGTX News  

MeiraGTx shares take off on $30M investment by Sanofi

By Proactive Investors
October 30, 2023

MeiraGTx shares take off on $30M investment by Sanofi

MeiraGTx Holdings PLC (NASDAQ:MGTX) shares gained more than 25% after it announced Sanofi SA (ADR) (NYSE:SNY), a pharma giant best known for its vacci more_horizontal

MeiraGTx shares jump as Sanofi invests in gene therapy

By Market Watch
October 30, 2023

MeiraGTx shares jump as Sanofi invests in gene therapy

Shares of MeiraGTx Holdings PLC MGTX, -4.88% jumped 14% premarket on Monday after the gene therapy company announced that French drugmaker Sanofi SNY, more_horizontal

MeiraGTx Holdings PLC (MGTX) Reports Q2 Loss, Misses Revenue Estimates

By Zacks Investment Research
August 10, 2023

MeiraGTx Holdings PLC (MGTX) Reports Q2 Loss, Misses Revenue Estimates

MeiraGTx Holdings PLC (MGTX) came out with a quarterly loss of $0.53 per share versus the Zacks Consensus Estimate of a loss of $0.59. This compares t more_horizontal

MeiraGTx Holdings PLC (MGTX) Soars 8.2%: Is Further Upside Left in the Stock?

By Zacks Investment Research
June 29, 2023

MeiraGTx Holdings PLC (MGTX) Soars 8.2%: Is Further Upside Left in the Stock?

MeiraGTx Holdings PLC (MGTX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revis more_horizontal

Does MeiraGTx Holdings PLC (MGTX) Have the Potential to Rally 320.9% as Wall Street Analysts Expect?

By Zacks Investment Research
June 2, 2023

Does MeiraGTx Holdings PLC (MGTX) Have the Potential to Rally 320.9% as Wall Street Analysts Expect?

The consensus price target hints at a 320.9% upside potential for MeiraGTx Holdings PLC (MGTX). While empirical research shows that this sought-after more_horizontal

MeiraGTx to Present Clinical Data from Phase 1 Trial of AAV-hAQP1 for Radiation-Induced Xerostomia on Tuesday, December 13, 2022

By GlobeNewsWire
December 8, 2022

MeiraGTx to Present Clinical Data from Phase 1 Trial of AAV-hAQP1 for Radiation-Induced Xerostomia on Tuesday, December 13, 2022

LONDON and NEW YORK, Dec. 08, 2022 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ: MGTX), a vertically integrated, clinical stage gene therapy more_horizontal


Search within

Pages Search Results: